EG18175A - Process for the preparing of compounds having a cognition adjuvant action, agents containing them and the use thereof in the treatment and prophylaxis of cognitive dysfunctions - Google Patents
Process for the preparing of compounds having a cognition adjuvant action, agents containing them and the use thereof in the treatment and prophylaxis of cognitive dysfunctionsInfo
- Publication number
- EG18175A EG18175A EG18087A EG18087A EG18175A EG 18175 A EG18175 A EG 18175A EG 18087 A EG18087 A EG 18087A EG 18087 A EG18087 A EG 18087A EG 18175 A EG18175 A EG 18175A
- Authority
- EG
- Egypt
- Prior art keywords
- prophylaxis
- treatment
- compounds
- preparing
- agents containing
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 239000002671 adjuvant Substances 0.000 title 1
- 230000019771 cognition Effects 0.000 title 1
- 208000010877 cognitive disease Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000001777 nootropic effect Effects 0.000 abstract 2
- 239000005541 ACE inhibitor Substances 0.000 abstract 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000007257 malfunction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Epoxy Compounds (AREA)
- Indole Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863610391 DE3610391A1 (de) | 1986-03-27 | 1986-03-27 | Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG18175A true EG18175A (en) | 1994-07-30 |
Family
ID=6297417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG18087A EG18175A (en) | 1986-03-27 | 1987-03-25 | Process for the preparing of compounds having a cognition adjuvant action, agents containing them and the use thereof in the treatment and prophylaxis of cognitive dysfunctions |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0243645B1 (cs) |
| JP (1) | JPS62240698A (cs) |
| KR (1) | KR870008841A (cs) |
| CN (1) | CN1031267C (cs) |
| AT (1) | ATE102954T1 (cs) |
| AU (1) | AU621278B2 (cs) |
| CA (1) | CA1341064C (cs) |
| CS (2) | CS212687A3 (cs) |
| DD (1) | DD280765A5 (cs) |
| DE (2) | DE3610391A1 (cs) |
| DK (1) | DK172221B1 (cs) |
| EG (1) | EG18175A (cs) |
| ES (1) | ES2061447T3 (cs) |
| FI (1) | FI91876C (cs) |
| HU (2) | HU202118B (cs) |
| IE (1) | IE62456B1 (cs) |
| MA (1) | MA20919A1 (cs) |
| NO (1) | NO178546C (cs) |
| NZ (1) | NZ219764A (cs) |
| OA (1) | OA08506A (cs) |
| PH (1) | PH27210A (cs) |
| PT (1) | PT84564B (cs) |
| RU (1) | RU1836335C (cs) |
| TN (1) | TNSN87045A1 (cs) |
| ZA (1) | ZA872230B (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5231084A (en) * | 1986-03-27 | 1993-07-27 | Hoechst Aktiengesellschaft | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons |
| US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
| CA1321753C (en) * | 1987-04-27 | 1993-08-31 | Abraham Sudilovsky | Method for inhibiting loss of cognitive functions employing an ace inhibitor |
| DE3731085A1 (de) * | 1987-09-16 | 1989-04-06 | Hoechst Ag | Neue aminosaeureester, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
| DE3739690A1 (de) * | 1987-11-24 | 1989-06-08 | Hoechst Ag | Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen |
| DE3801587A1 (de) * | 1988-01-21 | 1989-08-03 | Hoechst Ag | Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
| EP0331609A3 (de) * | 1988-01-27 | 1992-07-01 | Hoechst Aktiengesellschaft | Angiotensin-Converting-Enzym-Hemmstoffe mit psychotroper Wirkung |
| DE3803225A1 (de) * | 1988-02-04 | 1989-08-17 | Hoechst Ag | Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung |
| JPH01275529A (ja) * | 1988-03-21 | 1989-11-06 | E R Squibb & Sons Inc | 晩発性運動障害の抑制治療剤 |
| US5037821A (en) * | 1988-06-01 | 1991-08-06 | E. R. Squibb & Sons, Inc. | Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor |
| US5093129A (en) * | 1989-01-30 | 1992-03-03 | E. R. Squibb & Sons, Inc. | Method for treating addiction to a drug of abuse employing an ace inhibitor |
| US5032578A (en) * | 1990-09-17 | 1991-07-16 | E. R. Squibb & Sons, Inc. | Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| US20020187977A1 (en) * | 2001-03-15 | 2002-12-12 | Rodney Pearlman | Methods for restoring cognitive function following systemic stress |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3174844D1 (en) * | 1980-10-23 | 1986-07-24 | Schering Corp | Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them |
| DE3300774A1 (de) * | 1983-01-12 | 1984-07-12 | Hoechst Ag, 6230 Frankfurt | Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung |
-
1986
- 1986-03-27 DE DE19863610391 patent/DE3610391A1/de not_active Withdrawn
-
1987
- 1987-03-18 AT AT87103938T patent/ATE102954T1/de not_active IP Right Cessation
- 1987-03-18 DE DE87103938T patent/DE3789330D1/de not_active Expired - Lifetime
- 1987-03-18 ES ES87103938T patent/ES2061447T3/es not_active Expired - Lifetime
- 1987-03-18 EP EP87103938A patent/EP0243645B1/de not_active Expired - Lifetime
- 1987-03-25 MA MA21159A patent/MA20919A1/fr unknown
- 1987-03-25 DD DD87301118A patent/DD280765A5/de not_active IP Right Cessation
- 1987-03-25 EG EG18087A patent/EG18175A/xx active
- 1987-03-25 HU HU896609A patent/HU202118B/hu unknown
- 1987-03-25 HU HU871308A patent/HU203117B/hu unknown
- 1987-03-25 NZ NZ219764A patent/NZ219764A/en unknown
- 1987-03-25 PH PH35073A patent/PH27210A/en unknown
- 1987-03-25 FI FI871304A patent/FI91876C/fi not_active IP Right Cessation
- 1987-03-26 JP JP62070541A patent/JPS62240698A/ja active Pending
- 1987-03-26 KR KR870002775A patent/KR870008841A/ko not_active Ceased
- 1987-03-26 CA CA000533092A patent/CA1341064C/en not_active Expired - Lifetime
- 1987-03-26 PT PT84564A patent/PT84564B/pt unknown
- 1987-03-26 RU SU874202302A patent/RU1836335C/ru active
- 1987-03-26 ZA ZA872230A patent/ZA872230B/xx unknown
- 1987-03-26 NO NO871282A patent/NO178546C/no unknown
- 1987-03-26 AU AU70649/87A patent/AU621278B2/en not_active Expired
- 1987-03-26 DK DK153587A patent/DK172221B1/da not_active IP Right Cessation
- 1987-03-26 IE IE78487A patent/IE62456B1/en not_active IP Right Cessation
- 1987-03-27 TN TNTNSN87045A patent/TNSN87045A1/fr unknown
- 1987-03-27 CN CN87102304A patent/CN1031267C/zh not_active Expired - Lifetime
- 1987-03-27 CS CS872126A patent/CS212687A3/cs unknown
- 1987-03-27 OA OA59095A patent/OA08506A/xx unknown
- 1987-03-27 CS CS896519A patent/CS276385B6/cs not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT43582A (en) | Process for production of derivatives of 4,5,6-substituated-n-/substituated phenil/-piramidin-amin and medical compounds containing thereof | |
| GR860571B (en) | Labdan-derivatives process for their preparation and their use as medicaments | |
| EG18175A (en) | Process for the preparing of compounds having a cognition adjuvant action, agents containing them and the use thereof in the treatment and prophylaxis of cognitive dysfunctions | |
| EP0363415A4 (en) | Compounds for the treatment of alzheimer's disease | |
| ZA8996B (en) | Chemical compounds | |
| GR3019388T3 (en) | The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse | |
| IL89031A0 (en) | Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation | |
| ES8503643A1 (es) | Un procedimiento para la preparacion de compuestos de bis (carboxamida) | |
| PH24568A (en) | Use of bezafibrate for treating diabetes | |
| IE872540L (en) | Method of promoting wound-healing | |
| PT85602A (en) | Oxolabdanes a process for their preparation and their use as medicaments | |
| JO1516B1 (en) | Compounds with cognitive effectiveness, factors containing them, and their use in treatment and disease prevention for cognitive dysfunction | |
| MTP1001B (en) | Compounds having a cognition adjuvant action,agents containing them,and the use of there of for treatment and prophylaxis of cognitive dysfunctions (hoe 86/f069) | |
| HUT46537A (en) | Process for producing therapeutive and preventive pharmaceutical composition against asthma containing 2-/2-phenyl-2-/2-pyridyl/-ethyl/-2-imidazoline as active component | |
| YU137985A (en) | Process for treatment of used catalyzer containing vanadium |